Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
The aim of this study was to investigate the effects of soy isoflavones, vitamin D and their probable interactions in women with IBS.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Moreover, pregnant and lactating women were not recruited in the study.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Co-Administration of Soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease
Study design awaiting verification · PLoS ONE · 2016
Original publication title
Co-Administration of Soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease
© 2016 Jalili et al
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: Background and Aims
The substantial characteristics of Irritable Bowel Syndrome (IBS) are associated with estrogens in women. Both soy isoflavones and vitamin D can modulate estrogen receptors in the colonic smooth muscles. The aim of this study was to investigate the effects of soy isoflavones, vitamin D and their probable interactions in women with IBS.
Source: Background and AimsAbstract: What methods does the paper describe?
In a factorial blinded randomized clinical trial, 100 women with IBS (age:18-75yr, were randomly assigned in 4 arms to receive either placebo of vitamin D and placebo of soy isoflavones (P+P), or placebo of vitamin D and soy isoflavones (P+S), or vitamin D and placebo of soy isoflavones (D+P), or vitamin D and soy isoflavones (D+S) for 6 weeks. Dosage of soy isoflavone was 2 capsules of 20 mg soy isoflavones per day, and dosage of vitamin D was one pearl of 50’000 IU biweekly.
The clinical outcomes were IBS symptoms severity scores (IBS-SSS), disease: specific quality of life (IBS-QOL) and total score (IBS-TS) that evaluated at weeks 0, 6, and 10, and compared to each other.
Source: MethodsAbstract: Results
IBS-TS improved significantly in both S+P and D+P groups (p: value = 0.004, 0.015). The interaction effect of soy isoflavones and vitamin D on IBS-TS was significant (p<0.05). The interaction effect of soy isoflavones with vitamin D and the main effect of vitamin D on IBS-SSS were not statistically significant, whereas IBS-SSS decreased significantly in S+P and D+P groups (p-value = 0.001, 0.047 respectively).
Source: ResultsAbstract: Conclusion
Our results indicate that co-administration of soy isoflavones with vitamin D did not improve the IBS: SSS and IBS: QOL; however, it improved the IBS-TS.
Source: ConclusionAuthors’ abstract
Background and Aims
The substantial characteristics of Irritable Bowel Syndrome (IBS) are associated with estrogens in women. Both soy isoflavones and vitamin D can modulate estrogen receptors in the colonic smooth muscles. The aim of this study was to investigate the effects of soy isoflavones, vitamin D and their probable interactions in women with IBS.
Methods
In a factorial blinded randomized clinical trial, 100 women with IBS (age:18-75yr, were randomly assigned in 4 arms to receive either placebo of vitamin D and placebo of soy isoflavones (P+P), or placebo of vitamin D and soy isoflavones (P+S), or vitamin D and placebo of soy isoflavones (D+P), or vitamin D and soy isoflavones (D+S) for 6 weeks. Dosage of soy isoflavone was 2 capsules of 20 mg soy isoflavones per day, and dosage of vitamin D was one pearl of 50’000 IU biweekly.
The clinical outcomes were IBS symptoms severity scores (IBS-SSS), disease: specific quality of life (IBS-QOL) and total score (IBS-TS) that evaluated at weeks 0, 6, and 10, and compared to each other.
Results
IBS-TS improved significantly in both S+P and D+P groups (p: value = 0.004, 0.015). The interaction effect of soy isoflavones and vitamin D on IBS-TS was significant (p<0.05). The interaction effect of soy isoflavones with vitamin D and the main effect of vitamin D on IBS-SSS were not statistically significant, whereas IBS-SSS decreased significantly in S+P and D+P groups (p-value = 0.001, 0.047 respectively).
Conclusion
Our results indicate that co-administration of soy isoflavones with vitamin D did not improve the IBS: SSS and IBS: QOL; however, it improved the IBS-TS.
Trial Registration
Clinical Trials.gov NCT02026518
Publication and source details
Original title: Co-Administration of Soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease
Mahsa Jalili; Azita Hekmatdoost; Homayoon Vahedi; Hossein Poustchi; Behnam Khademi; Mohsen Saadi; Maryam Zemestani; Leila Janani
PLoS ONE · 2016
Competing Interests: The authors have declared that no competing interests exist.
Conceived and designed the experiments: MJ AH LJ HV.
Analyzed the data: LJ MJ.
Wrote the paper: MJ AH LJ BK MS MZ.
Full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis: AH.
Critical revision of the manuscript for important intellectual content: AH, LJ, MJ, HP, HV.
Statistical analysis: LJ, MJ.
Obtained funding: AH, HP, HV.
Administrative, technical, or material support: AH, HP, HV, BK, MS, MZ.
Study supervision: AH, HV, HP.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T09:11:06.117200+00:00
DOI: 10.1371/journal.pone.0158545 · PMC4973900